NTRK2 and breast cancer: High levels of NTRK2 and 3 demonstrated better associations with overall survival (OS) and recurrence-free survival (RFS) in BC patients (P < .05), while high levels of NTRK1 showed an applicable correlation with RFS in BC patients (P < .001).